Date of dispatch of this notice: 20/02/2023
Expire date: 01/03/2023
External Reference: 2023-279484
TED Reference: 2023/S 040-115145
Prior information notice
Information
Published
Prior information notice
Prior information notice
Services
Directive 2014/24/EU
This notice is for prior information only
Section I: Contracting authority
I.1)
Name and addresses
Health Service Executive (HSE)
N/A
Head Office
Naas
Millennium Park
IE
Contact person:
Aidan McGovern
Telephone:
+353 873666122
E-mail:
aidan.mcgovern@hse.ie
NUTS code:
IE0 -
IRELAND
Main address:
http://www.hse.ie
Address of the buyer profile:
https://irl.eu-supply.com/ctm/Company/CompanyInformation/Index/461
I.2)
Joint procurement
The contract is awarded by a central purchasing body
I.3)
Communication
The procurement documents are available for unrestricted and full direct access, free of charge, at:
http://irl.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=234465&B=ETENDERS_SIMPLEAdditional information can be obtained from
the abovementioned address:
I.4)
Type of the contracting authority
Body governed by public law
I.5)
Main activity
Health
Section II: Object
II.1)
Scope of the procurement
II.1.1)
Title
Invitation to Participate in an Authorisation Scheme for General Practitioners Direct Access to Community Diagnostics - MRI, CT, DEXA & X-Ray PIN
Reference number:
HSE19974
II.1.2)
Main CPV code
85150000
-
Medical imaging services
II.1.3)
Type of contract
Services
II.1.4)
Short description
Invitation to Participate in an Authorisation Scheme for General Practitioners Direct Access to Community Diagnostics - MRI, CT, DEXA & X-Ray PIN
II.1.5)
Estimated total value
Value excluding VAT: 35000000.00
EUR
II.1.6)
Information about lots
This contract is divided into lots:
no
II.2)
Description
II.2.2)
Additional CPV code(s)
85150000
-
Medical imaging services
II.2.3)
Place of performance
NUTS code:
IE0 -
IRELAND
II.2.4)
Description of the procurement
National Primary Care Strategy and HSE Procurement intend to establish an authorisation scheme to secure suitable suppliers located in Ireland to meet the requirements of patients to access community diagnostics through their general practitioners, which includes the provision of MRI, CT, DEXA & X-Ray examinations in approved provider locations of a patient's choice (the “Scheme”).
This Authorisation Scheme is separated into 4 lots as follows:
- Lot 1: MRI
- Lot 2: CT
- Lot 3: X-Ray
- Lot 4: Dexa
The services will be delivered using service providers’ equipment with radiologists, and radiographers provided by the service provider completing exams and reporting back to the referring GP as per Specification of Requirements.
The service will provide patients with direct access through their general practitioner to examinations outlined above and set out by Section 2.4 of the Scheme Application, for full population for 2023. This will be reviewed annually with the service providers and interested parties are advised that this may revert to GMS, GP Visit Card, and HAA adult patients (over the age of 16 years) only, during the term of the contract.
Interested parties are advised that although the Scheme is being advertised on eTenders and in the Official Journal of the European Union by way of a Prior Information Notice, this is in fact a simple authorisation scheme established pursuant to Recital 4 of Directive 2014/24/EU (the “Directive”) and accordingly is outside of the scope of the Directive – see Section II.2.4 (Description of the Procurement) below for further detail on the Scheme.
Lots 1 – 4: The initial term for each of these lots is 2 years (which may be extended for 3 x 12-month periods at the absolute discretion of the HSE).
National Primary Care Strategy and HSE Procurement intend to establish the Scheme to secure suitable suppliers located in Ireland to meet the requirements of patients to access to Community Diagnostics through their general practitioners, which includes the provision of MRI, CT, DEXA & X-Ray examinations in approved provider locations of a patient's choice.
Interested parties are advised that although the Scheme is being advertised on eTenders and in the Official Journal of the European Union by way of a Prior Information Notice, this is in fact a simple authorisation scheme established pursuant to Recital 4 of the Directive and accordingly is outside of the scope of the Directive.
The HSE will publish a Prior Information Notice (“PIN”) on eTenders and in the Official Journal of the European Union every 6 months during the term of the above referenced lots, inviting parties to apply to join the Scheme.
While this Scheme is outside the scope of the Directive, it is being advertised on eTenders and in the Official Journal of the European Union by way of Prior Information Notice to boost participation in the Scheme.
Interested parties are invited to review the PIN and Scheme Application, including the accompanying appendix for further information regarding the requirements of the Scheme.
Scheme Applicants that successfully meet the minimum requirements (as specified in Section 2 of the Scheme Application) will progress to the next stage of the Scheme (“Shortlisted Scheme Applicants”). Failure to meet any of the minimum requirements (as specified in Section 2 of the Scheme Application) will result in the Scheme Application being rejected. At the next stage of the Scheme, Shortlisted Scheme Applicants will be issued with the applicable price and Service Level Agreement.
This Authorisation Scheme is separated into 4 lots as follows:
- Lot 1: MRI
- Lot 2: CT
- Lot 3: X-Ray
- Lot 4: Dexa
The services will be delivered using service providers’ equipment with radiologists, and radiographers provided by the service provider completing exams and reporting back to the referring GP as per Specification of Requirements.
The service will provide patients with direct access through their general practitioner to examinations outlined above and set out by Section 2.4 of the Scheme Application, for full population for 2023. This will be reviewed annually with the service providers and interested parties are advised that this may revert to GMS, GP Visit Card, and HAA adult patients (over the age of 16 years) only, during the term of the contract.
Interested parties are advised that although the Scheme is being advertised on eTenders and in the Official Journal of the European Union by way of a Prior Information Notice, this is in fact a simple authorisation scheme established pursuant to Recital 4 of Directive 2014/24/EU (the “Directive”) and accordingly is outside of the scope of the Directive – see Section II.2.4 (Description of the Procurement) below for further detail on the Scheme.
Lots 1 – 4: The initial term for each of these lots is 2 years (which may be extended for 3 x 12-month periods at the absolute discretion of the HSE).
National Primary Care Strategy and HSE Procurement intend to establish the Scheme to secure suitable suppliers located in Ireland to meet the requirements of patients to access to Community Diagnostics through their general practitioners, which includes the provision of MRI, CT, DEXA & X-Ray examinations in approved provider locations of a patient's choice.
Interested parties are advised that although the Scheme is being advertised on eTenders and in the Official Journal of the European Union by way of a Prior Information Notice, this is in fact a simple authorisation scheme established pursuant to Recital 4 of the Directive and accordingly is outside of the scope of the Directive.
The HSE will publish a Prior Information Notice (“PIN”) on eTenders and in the Official Journal of the European Union every 6 months during the term of the above referenced lots, inviting parties to apply to join the Scheme.
While this Scheme is outside the scope of the Directive, it is being advertised on eTenders and in the Official Journal of the European Union by way of Prior Information Notice to boost participation in the Scheme.
Interested parties are invited to review the PIN and Scheme Application, including the accompanying appendix for further information regarding the requirements of the Scheme.
Scheme Applicants that successfully meet the minimum requirements (as specified in Section 2 of the Scheme Application) will progress to the next stage of the Scheme (“Shortlisted Scheme Applicants”). Failure to meet any of the minimum requirements (as specified in Section 2 of the Scheme Application) will result in the Scheme Application being rejected. At the next stage of the Scheme, Shortlisted Scheme Applicants will be issued with the applicable price and Service Level Agreement.
II.3)
Estimated date of publication of contract notice:
01/04/2023
Section IV: Procedure
IV.1)
Description
IV.1.8)
Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement
: no
IV.2)
Administrative information
Section VI: Complementary information
VI.3)
Additional information
Response Details
Interested parties are requested to submit their response to the Scheme Application to the address below:
Aidan McGovern
HSE Procurement – Sourcing and Contracts. | Health Service Executive | Email: aidan.mcgovern@hse.ie Tel: 087 3666122
The closing date for responses to the Scheme Application is 19:00 1st March 2023. It is envisaged that the process will be operational for patients by the 1st April 2023.
Details of the service providers that are ultimately appointed to the Scheme be provided to patients by GPs. The patients will choose which service provider s/he wishes to use.
Interested parties are requested to submit their response to the Scheme Application to the address below:
Aidan McGovern
HSE Procurement – Sourcing and Contracts. | Health Service Executive | Email: aidan.mcgovern@hse.ie Tel: 087 3666122
The closing date for responses to the Scheme Application is 19:00 1st March 2023. It is envisaged that the process will be operational for patients by the 1st April 2023.
Details of the service providers that are ultimately appointed to the Scheme be provided to patients by GPs. The patients will choose which service provider s/he wishes to use.